References
- Stamm WE, McKevitt M, Roberts PL et al. Natural history of recurrent urinary tract infections in women. Rev Infect Dis. 1991; 13(1): 77-84.
- Speciale A, G. Nicoletti, R. Musumeci et al. Prevalenza e antibiotico-resistenza dei principali patogeni urinari responsabili di cistiti non complicate della donna: lo studio ICEA2. GIMMOC VIII, Q1, 2004.
- Fadda G, Nicoletti G, Schito GC. Progetto nazionale per la sorveglianza delle infezioni batteriche gravi in ambito comunitario e ospedaliero. Istituto Superiore di Sanità, 2004.
- Peterson LR, ICID 2002, Abstract #01404.
- Drlica K, Schmitz FJ. Therapeutic options in an era of decreasing antimicrobial susceptibility. J Chemother. 2002; 14 Suppl 2: 5-12.
- Gupta K, Hooton TM, Stamm WE. Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections. Ann Intern Med. 2001; 135(1): 41-50.
- Lode H, Fassbender M, Schaberg T et al. Comparative pharmacokinetics of the new oral cephalosporins. Drugs 1994; 47 Suppl 3:10-9.
- Perry CM, Brogden RN. Cefuroxime axetil. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy. Drugs. 1996; 52(1): 125-58.
- Fuchs PC, Barry AL, Brown SD. Fosfomycin tromethamine susceptibility of outpatient urine isolates of Escherichia coli and Enterococcus faecalis from ten North American medical centres by three methods. J Antimicrob Chemother. 1999; 43(1): 137-40.
- Schaeffer AJ. The expanding role of fluoroquinolones. Am J Med. 2002; 113 Suppl 1A:45S-54S.
- Pickerill KE, Paladino JA, Schentag JJ. Comparison of the fluoroquinolones based on pharmacokinetic and pharmacodynamic parameters. Pharmacotherapy. 2000; 20(4): 417-28.
- Picollo R, Brion N, Gualano V et al. Pharmacokinetics and tolerability of prulifloxacin after single oral administration. Arzneimittelforschung. 2003; 53(3): 201-5.
- Naber KG, Bergman B, Bishop MC et al. EAU guidelines for the management of urinary and male genital tract infections. Urinary Tract Infection (UTI) Working Group of the Health Care Office (HCO) of the European Association of Urology (EAU). Eur Urol. 2001; 40(5): 576-88.
- Warren J, Abrutyn E, Hebel JR et al. Guidelines for Antimicrobial Treatment of Uncomplicated Acute Bacterial Cystitis and Acute Pyelonephritis in Women. Clin Infect Dis 1999; 29: 745-58
- Naber KG, Landen H. Rapid resolution of symptoms with ciprofloxacin therapy in 3859 hospitalised patients with urinary tract infection. Int J Antimicrob Agents. 2004; 23 Suppl 1: S35-40.
- Pavone-Macaluso M, Abadessa D, Pavone C et al. Le prostatiti in “Le infezioni del tratto urinario” a cura di Lotti T e Mirone V, Pacini. Editore Pisa 2004: 89-101.
- Litwin MS, McNaughton Collins M et al. National Institute of Health Chronic Prostatitis Symptoms Index: development and validation of new outcome measure. Chronic Prostatitis Collaborative Research Network. J Urol 1999; 162 (2): 369-375.
- Naber KG, Sorgel F. Antibiotic therapy–rationale and evidence for optimal drug concentrations in prostatic and seminal fluid and in prostatic tissue. Andrologia. 2003; 35(5): 331-5.
- Foxman B, Barlow R, D’Arcy H et al. Urinary tract infection: self-reported incidence and associated costs. Ann Epidemiol. 2000; 10(8): 509-15.
- Schaeffer A.J. Infezioni ed infiammazioni dell’apparato genito-urinario in “Urologia”, Campbell, VII ed. 1998.
- Fihn SD. Acute uncomplicated urinary tract infection in women. NEJM 2003; 349: 259-66
- Krieger JN, Nyberg L Jr, Nickel JC. NIH consensus definition and classification of prostatitis. JAMA. 1999; 282(3): 236-7.
- Potts JM. Prospective identification of National Institutes of Health category IV prostatitis in men with elevated prostate specific antigen. J Urol. 2000; 164(5): 1550-3.
- Bozeman CB, Carter BS, Eastham JA et al. Treatment of chronic prostatitis lowers serum prostate specific antigen. J Urol. 2002; 167(4): 1723-6.
- Lorente JA, Arango O, Bielsa O et al. Effect of antibiotic treatment on serum PSA and percent free PSA levels in patients with biochemical criteria for prostate biopsy and previous lower urinary tract infections. Int J Biol Markers. 2002; 17(2):84-9.
- Bulbul MA, Wazzan W, Hijaz A et al. The effect of antibiotics on elevated serum prostate specific antigen in patients with urinary symptoms and negative digital rectal examination: a pilot study. J Med Liban. 2002; 50(1-2): 23-5.
- Guercio S, Terrone C, Tarabuzzi R et al. PSA decrease after levofloxacin therapy in patients with histological prostatitis. Arch Ital Urol Androl. 2004; 76(4): 154-8.